Auditing Physician Contracts Under the New Stark Rules

  • Check with publisher
  • Published date: March 1, 2019
    • Fremont, California, United States

Overview:

In this session Mr. Wolfe will provide an overview of the Stark Law, including its recent changes. He will also discuss best practices for auditing physician compensation arrangements on behalf of health systems, hospitals, medical groups and physician practices. The webinar will focus on regulatory requirements, key provisions, valuation considerations and potential pitfalls that should be avoided.

Why should you Attend: This webinar will offer best practices for implementing and auditing physician compensation arrangements to minimize liability exposure and penalties, including conducting compliance audits, instituting policies, and establishing ongoing monitoring and reviews.

Event link: https://www.mentorhealth.com/webinar/-801597LIVE?channel=sciencemarketplace-May_2019_SEO
Contact Info:
Netzealous LLC - MentorHealth
Phone No: 1-800-385-1607
Fax: 302-288-6884
Email: mentorhealth84@gmail.com
Website: http://www.mentorhealth.com/

Result 0 votes
Roger Steven
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Inactivated HAV Antigen (Human)

    Inactivated HAV Antigen (Human)

    Pharmacology - Drug Development Shirley (New York) August 29, 2019 Check with publisher

    The Hepatitis A virus (HAV), or Hepatovirus A, is a virus of the Picornaviridae family. It takes human and vertebrates as its natural hosts. HAV isolates all belong to a single serotype, seven genetic groups now have been defined, four for humans (ge...

  • Anti-CD22 (clone 10F4v3)-Mc-VC-PABC-MMAE ADC

    Anti-CD22 (clone 10F4v3)-Mc-VC-PABC-MMAE ADC

    Pharmacology - Drug Development Shirley (New York) August 27, 2019 Check with publisher

    This ADC product is comprised of an anti-CD22 monoclonal antibody (clone 10F4v3) conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosi...

  • Recombinant Human CD226 Protein(Fc tag)

    Recombinant Human CD226 Protein(Fc tag)

    Pharmacology - Drug Development Shirley (New York) May 30, 2019 Check with publisher

    Receptor involved in intercellular adhesion, lymphocyte signaling, cytotoxicity and lymphokine secretion mediated by cytotoxic T-lymphocyte (CTL) and NK cell. Recombinant Human CD226 Protein (Q15762) (Glu 19 - Asn 247) with a human IgG1 Fc tag at the...